Michel Detheux I Teos Therapeutics, Inc. (ITOS) insider trading activity

Michel Detheux is Chief Executive Officer of iTeos Therapeutics, Inc.. Currently has a direct ownership of 58,903 shares of ITOS, which is worth approximately $601,399. The most recent transaction as insider was on Aug 31, 2021, when has been sold 4,093 shares (Common Stock) at a price of $28.12 per share, resulting in proceeds of $115,095. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.9K

0% 3M change

124.28% 12M change

Total Value Held $601,399

Michel Detheux Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2021	SELL Open market or private sale	$115,095 $28.12 p/Share	4,093 Reduced 3.15%	125,689 Common Stock
Aug 30 2021	SELL Open market or private sale	$65,039 $28.01 p/Share	2,322 Reduced 1.76%	129,782 Common Stock
Aug 27 2021	SELL Open market or private sale	$232,346 $28.17 p/Share	8,248 Reduced 5.88%	132,104 Common Stock
Aug 25 2021	SELL Open market or private sale	$24,108 $28.0 p/Share	861 Reduced 0.61%	140,352 Common Stock
Aug 24 2021	SELL Open market or private sale	$6,359 $28.26 p/Share	225 Reduced 0.16%	141,213 Common Stock
Aug 23 2021	SELL Open market or private sale	$210,422 $28.06 p/Share	7,499 Reduced 5.04%	141,438 Common Stock
Jun 14 2021	SELL Open market or private sale	$835,780 $28.82 p/Share	29,000 Reduced 16.3%	148,937 Common Stock

Michel Detheux

Chief Executive Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Value

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

Operation

Value

Type

News

Receive news related to iTeos Therapeutics, Inc.

Track Activities on ITOS

Account